Novo Nordisk A/S (NVO) — Quality & forensics

As of 2026-10-06 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.

The Closelooknet module scores

54 /100 composite · 7 modules · general weight set

Valuation 74
Quality 87
Growth 32
Balance sheet 48
Cash quality 34
Capital allocation 66
Momentum 23

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

2.05 Altman Z-Score

Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

5/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.71 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the NVO chart & overview

FAQ · from the current data · as of 2026-10-06

Quick answers

What is Novo Nordisk A/S's Closelooknet quality reading?

The composite reads 54/100 across 7 modules, as of 2026-10-06: valuation 74, quality 87, growth 32, balance sheet 48, cash quality 34, capital allocation 66, momentum 23. Closelooknet scores are research diary readings, not ratings or investment advice.

What is Novo Nordisk A/S's Altman Z-Score?

2.05, which sits in the grey zone (1.81–2.99) as of 2026-10-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Novo Nordisk A/S's Piotroski F-Score?

5 of 9, as of 2026-10-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Novo Nordisk A/S's Beneish M-Score indicate?

-2.71 — below the −1.78 manipulation-risk threshold, as of 2026-10-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.